SoftOx Solutions
Mindre end 1K følgere
SOFTX
Euronext Growth Oslo
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Investorkonsensus
SoftOx Solutions is a Norwegian medical technology company. The company has developed a proprietary solution based on acetic acid for the treatment of chronic wounds in patients. The solution is used to eliminate infections associated with biofilms, which consist of different clusters of bacteria. Part of the drug development is done in collaboration with other research institutes. SoftOx Solutions was founded in 2012 and is headquartered in Oslo, Norway.
Læs mereMarkedsværdi
-
Aktieomsætning
-
Omsætning
7,91 mio.
EBIT %
-410,37 %
P/E
-
Udbytteafkast, %
-
Finanskalender
25.3
2026
Årsrapport '25
23.6
2026
Generalforsamling '26
24.6
2026
Delårsrapport Q1'26
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
SoftOx Solutions AS: First Subject Dosed in Combined Phase 2a Dose-Escalation and Proof-of-Concept Trial (SIS-03)
SoftOx Defense Solutions AS: HPRA Approves SIS-02 Phase 1 Trial, Strengthening Dual-Use and Preparedness Strategy
Bliv en del af Inderes community
Gå ikke glip af noget - opret en konto og få alle de mulige fordele
Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer